{"id":476094,"date":"2021-04-14T08:04:00","date_gmt":"2021-04-14T12:04:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/"},"modified":"2021-04-14T08:04:00","modified_gmt":"2021-04-14T12:04:00","slug":"biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/","title":{"rendered":"BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MISSISSAUGA, Ontario, April  14, 2021  (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming Bloom Burton &amp; Co. Healthcare Investor Conference. The conference will be held virtually on Tuesday, April 20 and Wednesday, April 21, 2021 between 8:30 am and 5:00 pm ET. \u00a0\u00a0 Mr. Ren\u00e9 Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent\u2019s business and corporate activities on April 21 at 11:00 am. Mr. Goehrum will also be available to meet virtually with investors on a one-on-one basis during the conference. These one-on-one meetings can be requested by attendees after registering for the conference: <a href=\"https:\/\/www.meetmax.com\/sched\/event_71993\/conference_register.html\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.meetmax.com\/sched\/event_71993\/conference_register.html<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About BioSyent Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Listed on the TSX Venture Exchange under the trading symbol \u201cRX\u201d, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, specialty, and international business units.<\/p>\n<p align=\"justify\">As of the date of this press release, the Company has 12,706,275 common shares outstanding.<\/p>\n<p align=\"justify\">For a direct market quote for the TSX Venture Exchange and other Company financial information please visit <a href=\"http:\/\/www.tmxmoney.com\/\" rel=\"nofollow noopener\" target=\"_blank\">www.tmxmoney.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>For further information please contact:<\/strong>\n      <\/p>\n<p align=\"justify\">Mr. Ren\u00e9 C. Goehrum<br \/>President and CEO<br \/>BioSyent Inc.<br \/>E-Mail: <a href=\"mailto:investors@biosyent.com\" rel=\"nofollow noopener\" target=\"_blank\">investors@biosyent.com<\/a><br \/>Phone: 905-206-0013<br \/>Web: <a href=\"http:\/\/www.biosyent.com\" rel=\"nofollow noopener\" target=\"_blank\">www.biosyent.com<\/a><\/p>\n<p align=\"justify\">\n        <i>This press release may contain information or statements that are forward-looking.\u00a0 The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be materially different from the forward-looking information or statements.\u00a0 Potential risks may include, but are not limited to, those associated with clinical trials, product development, future revenue, operations, profitability and obtaining regulatory approvals.<\/i><br \/>\n        <i>\u00a0<\/i>\n      <\/p>\n<p align=\"left\">\n        <i>Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.<\/i>\n      <\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjE3MSM0MTE4ODA3IzIwODk2Njc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/18645615-575d-48e3-a339-eeea0f1f8ec9\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MISSISSAUGA, Ontario, April 14, 2021 (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming Bloom Burton &amp; Co. Healthcare Investor Conference. The conference will be held virtually on Tuesday, April 20 and Wednesday, April 21, 2021 between 8:30 am and 5:00 pm ET. \u00a0\u00a0 Mr. Ren\u00e9 Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent\u2019s business and corporate activities on April 21 at 11:00 am. Mr. Goehrum will also be available to meet virtually with investors on a one-on-one basis during the conference. These one-on-one meetings can be requested by attendees after registering for the conference: https:\/\/www.meetmax.com\/sched\/event_71993\/conference_register.html. About BioSyent Inc. Listed on the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-476094","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MISSISSAUGA, Ontario, April 14, 2021 (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming Bloom Burton &amp; Co. Healthcare Investor Conference. The conference will be held virtually on Tuesday, April 20 and Wednesday, April 21, 2021 between 8:30 am and 5:00 pm ET. \u00a0\u00a0 Mr. Ren\u00e9 Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent\u2019s business and corporate activities on April 21 at 11:00 am. Mr. Goehrum will also be available to meet virtually with investors on a one-on-one basis during the conference. These one-on-one meetings can be requested by attendees after registering for the conference: https:\/\/www.meetmax.com\/sched\/event_71993\/conference_register.html. About BioSyent Inc. Listed on the &hellip; Continue reading &quot;BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-14T12:04:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjE3MSM0MTE4ODA3IzIwODk2Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference\",\"datePublished\":\"2021-04-14T12:04:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/\"},\"wordCount\":359,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNjE3MSM0MTE4ODA3IzIwODk2Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/\",\"name\":\"BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNjE3MSM0MTE4ODA3IzIwODk2Njc=\",\"datePublished\":\"2021-04-14T12:04:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNjE3MSM0MTE4ODA3IzIwODk2Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNjE3MSM0MTE4ODA3IzIwODk2Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference - Market Newsdesk","og_description":"MISSISSAUGA, Ontario, April 14, 2021 (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming Bloom Burton &amp; Co. Healthcare Investor Conference. The conference will be held virtually on Tuesday, April 20 and Wednesday, April 21, 2021 between 8:30 am and 5:00 pm ET. \u00a0\u00a0 Mr. Ren\u00e9 Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent\u2019s business and corporate activities on April 21 at 11:00 am. Mr. Goehrum will also be available to meet virtually with investors on a one-on-one basis during the conference. These one-on-one meetings can be requested by attendees after registering for the conference: https:\/\/www.meetmax.com\/sched\/event_71993\/conference_register.html. About BioSyent Inc. Listed on the &hellip; Continue reading \"BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-14T12:04:00+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjE3MSM0MTE4ODA3IzIwODk2Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference","datePublished":"2021-04-14T12:04:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/"},"wordCount":359,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjE3MSM0MTE4ODA3IzIwODk2Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/","name":"BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjE3MSM0MTE4ODA3IzIwODk2Njc=","datePublished":"2021-04-14T12:04:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjE3MSM0MTE4ODA3IzIwODk2Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNjE3MSM0MTE4ODA3IzIwODk2Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-to-present-at-2021-bloom-burton-co-healthcare-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioSyent to Present at 2021 Bloom Burton &amp; Co. Healthcare Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=476094"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476094\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=476094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=476094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=476094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}